Sunday, April 20, 2014 2:15:48 AM
AMBS share price got hammered last year when they failed to file on time and there is no reason to think otherwise this time around.
Longs making excuses for GC and AMBS will compress timelines and throw out best case scenarios all day long but commercialization of Lympro and POTENTIAL revenues will not arrive for 5-6 months IMO.
I hold 300,000 shares at .0751 and still believe in AMBS long term but I think shares will be available well below the 50MA before the next leg up. I can understand the knee jerk reaction for major shareholders to come to Gerald's defense but my hat goes off to those willing to be honest here and admit they are pissed off and rightfully so!
Sumo
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM